Conjunctivitis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:


Shown below tables of conjunctivitis medical therapy:<ref name="pmid23114684">{{cite journal| author=| title=Drugs for some common eye disorders. | journal=Treat Guidel Med Lett | year= 2012 | volume= 10 | issue= 123 | pages= 79-86; quiz 2 p following 86 | pmid=23114684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23114684  }} </ref>
Shown below tables of conjunctivitis medical therapy:<ref name="pmid23114684">{{cite journal| author=| title=Drugs for some common eye disorders. | journal=Treat Guidel Med Lett | year= 2012 | volume= 10 | issue= 123 | pages= 79-86; quiz 2 p following 86 | pmid=23114684 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23114684  }} </ref>
<SMALL><font color="#FF4C4C">'''▸ Click on the following categories to expand treatment regimens.'''</font></SMALL>
{|
| valign=top |
<div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #A1BCDD; text-align: center;">
<font color="#FFF">
'''Conjunctivitis Medical Therapy'''
</font>
</div>
<div class="mw-customtoggle-table12" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Bacterial Conjunctivitis'''
</font>
</div>
<div class="mw-customtoggle-table14" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Newborn Conjunctivitis'''
</font>
</div>
<div class="mw-customtoggle-table15" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viral Conjunctivitis'''
</font>
</div>
| valign=top |
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table12" style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Bacterial Conjunctivitis}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align= Left | '''''Non-gonococcal'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Gatifloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Levofloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''<BR> OR <BR>▸ '''''[[Moxifloxacin]] 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align= Left | '''''Gonococcal'''''
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 1 gm IM/IV as 1 dose'''''
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ciprofloxacin]] 25-50 mg/kg IV/IM (not to exceed 125 mg) as 1 dose'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen (for non-gonococcal only)'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Polymyxin B]] + [[Trimethoprim]] 1–2 gtts q3–6h x 7–10 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] 1%, 1 gtt bid x 2 days, then 1 gtt daily x 5 days'''''
|-
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Chlamydia Trachomatis}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Preferred Regimen'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Azithromycin]] 1 gm once or twice weekly'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''Alternative Regimen'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Doxycycline]] 100 mg bid po x 7 days'''''
|-
|}
|}
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table14" style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Newborn Conjunctivitis}}
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Neisseria gonorrhoeae]] (after 2-5 days)'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | ''''' [[Chlamydia trachomatis]] (after 3-10 days)'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Erythromycin]] base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days'''''<BR> OR <BR> ▸ '''''[[Azithromycin ]] suspension 20 mg/kg po q24h x 3 days'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5" align=center | '''''[[Herpes simplex]] (after  2-16 days) †'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Acyclovir]] 60 mg/kg/day IV divided into 3 daily doses'''''<BR> OR <BR> ▸ '''''[[Trifluridine]] OR [[Vidarabine]] as a topical antiviral therapy'''''
|-
|† Systemic and CNS disease should be evaluated with PCR of CSF and serum and LFTs in any child with suspected HSV eye infection.
|-
|}
|}
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table15" style="background: #FFFFFF;"
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Viral Conjunctivitis (pink eye)}}
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''No treatment, but if symptomatic, use cold artificial tears'''''
|-
|}
|}
|}


==References==
==References==

Revision as of 20:18, 3 February 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis medical therapy

CDC on Conjunctivitis medical therapy

Conjunctivitis medical therapy in the news

Blogs on Conjunctivitis medical therapy

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis medical therapy

Medical Therapy

Pharmacotherapy

Acute Pharmacotherapies

Conjunctivitis sometimes requires medical attention. The appropriate treatment depends on the cause of the problem. For the allergic type, cool water constricts capillaries, and artificial tears sometimes relieve discomfort in mild cases. In more severe cases, non-steroidal anti-inflammatory medications and antihistamines may be prescribed. Some patients with persistent allergic conjunctivitis may also require topical steroid drops.

Bacterial conjunctivitis is usually treated with antibiotic eye drops or ointments that cover a broad range of bacteria (chloramphenicol or fusidic acid used in UK). However evidence suggests that this does not affect symptom severity and gains only modest reduction in duration from an average of 4.8 days (untreated controls) to 3.3 days for those given immediate antibiotics. Deferring antibiotics yields almost the same duration as those immediately starting treatment with 3.9 days duration, but with half the two-week clinic reattendance rate.[1]

Although there is no cure for viral conjunctivitis, symptomatic relief may be achieved with cool compresses and artificial tears. For the worst cases, topical corticosteroid drops may be prescribed to reduce the discomfort from inflammation. However prolonged usage of corticosteroid drops increases the risk of side effects. Antibiotic drops may also be used for treatment of complementary infections. Patients are often advised to avoid touching their eyes or sharing towels and washcloths. Viral conjunctivitis usually resolves within 3 weeks. However in worst cases it may take over a month.

Conjunctivitis due to burns, toxic and chemical require careful wash-out with saline, especially beneath the lids, and may require topical steroids. The more acute chemical injuries are medical emergencies, particularly alkali burns, which can lead to severe scarring, and intraocular damage. Fortunately, such injuries are uncommon.

Shown below tables of conjunctivitis medical therapy:[2]

▸ Click on the following categories to expand treatment regimens.

Conjunctivitis Medical Therapy

  ▸  Bacterial Conjunctivitis

  ▸  Newborn Conjunctivitis

  ▸  Viral Conjunctivitis

Bacterial Conjunctivitis
Preferred Regimen
Non-gonococcal
Ciprofloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days
OR
Gatifloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days
OR
Levofloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days
OR
Moxifloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days
Gonococcal
Adult dose
Ciprofloxacin 1 gm IM/IV as 1 dose
Pediatric dose
Ciprofloxacin 25-50 mg/kg IV/IM (not to exceed 125 mg) as 1 dose
Alternative Regimen (for non-gonococcal only)
Polymyxin B + Trimethoprim 1–2 gtts q3–6h x 7–10 days
OR
Azithromycin 1%, 1 gtt bid x 2 days, then 1 gtt daily x 5 days
Chlamydia Trachomatis
Preferred Regimen
Azithromycin 1 gm once or twice weekly
Alternative Regimen
Doxycycline 100 mg bid po x 7 days
Newborn Conjunctivitis
Neisseria gonorrhoeae (after 2-5 days)
Ceftriaxone 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)
Chlamydia trachomatis (after 3-10 days)
Erythromycin base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days
OR
Azithromycin suspension 20 mg/kg po q24h x 3 days
Herpes simplex (after 2-16 days) †
Acyclovir 60 mg/kg/day IV divided into 3 daily doses
OR
Trifluridine OR Vidarabine as a topical antiviral therapy
† Systemic and CNS disease should be evaluated with PCR of CSF and serum and LFTs in any child with suspected HSV eye infection.
Viral Conjunctivitis (pink eye)
No treatment, but if symptomatic, use cold artificial tears

References

  1. Hazel A Everitt, Paul S Little, Peter W F Smith (2006). "A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice". BMJ.Error: Bad DOI specified!. Unknown parameter |month= ignored (help)
  2. "Drugs for some common eye disorders". Treat Guidel Med Lett. 10 (123): 79–86, quiz 2 p following 86. 2012. PMID 23114684.


Template:WikiDoc Sources